March 19, 2018 7:31 AM ET


Company Overview of Haemostatix Ltd.

Company Overview

Haemostatix Ltd. develops a peptide-based platform technology to develop a pipeline of products to treat surgical bleeding with further applications in tissue repair and regenerative medicine. Its pipeline includes PeproStat, a coagulant/haemostat that is applied directly to a wound during surgery to control bleeding. The company was founded in 2003 and is based in Nottingham, United Kingdom. As of May 24, 2016, Haemostatix Ltd. operates as a subsidiary of Ergomed plc.

BioCity Nottingham

Pennyfoot Street

Nottingham,  NG1 1GF

United Kingdom

Founded in 2003


44 11 5912 4512

Key Executives for Haemostatix Ltd.

Chief Executive Officer and Director
Co-Founder, Chairman of the Scientific Advisory Board, Chief Scientific Officer and Director
Co-Founder, Chief Technology Officer and Director
Consultant Medical Director
Vice President of Research
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
Abcellute Ltd. Europe
Abcodia Ltd. Europe
Abeterno Ltd. Europe
Abgentis Limited Europe
Achilles Therapeutics Ltd. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Haemostatix Ltd., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at